A novel selective broad-spectrum anti-DNA virus agent

Area of Science:

• Virology
• Pharmacology
• Antiviral Research

Background:

• Development of novel antiviral agents is crucial for combating viral infections.
• Existing antiviral drugs face challenges with resistance, particularly in herpes viruses.
• (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine ((S)-HPMPA) is a newly identified compound with potential antiviral properties.

Purpose of the Study:

• To evaluate the antiviral spectrum and potency of (S)-HPMPA.
• To assess the efficacy of (S)-HPMPA against various DNA viruses and retroviruses, including drug-resistant mutants.
• To determine the in vivo effectiveness of (S)-HPMPA in animal models of viral infection.

Main Methods:

• In vitro susceptibility testing against a panel of DNA viruses and retroviruses.
• Testing against thymidine kinase-deficient (TK-) mutants of herpes simplex virus and varicella zoster virus.
• In vivo efficacy studies in mice and rabbits with herpes simplex virus type 1 infections.

Main Results:

• (S)-HPMPA exhibited potent and selective activity against a broad spectrum of DNA viruses, including herpes simplex virus (types 1 and 2), varicella zoster virus, human cytomegalovirus, and others.
• The compound was also active against retroviruses and TK-deficient mutants resistant to classical anti-herpes drugs.
• In vivo studies demonstrated (S)-HPMPA's effectiveness against local and systemic herpes simplex virus type 1 infections in mice and rabbits, including TK- mutant-induced keratitis.

Conclusions:

• (S)-HPMPA is a potent antiviral compound with broad-spectrum activity against numerous DNA viruses and retroviruses.
• Its efficacy against drug-resistant viral strains and in vivo models highlights its therapeutic potential.
• (S)-HPMPA represents a promising candidate for the treatment of various viral infections.